PDPramath Doddaballapur

Pramath Doddaballapur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pramath Doddaballapur has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Targeting mTOR to Mitigate Sequelae of Chronic Hypoxia on the Carotid Artery and Cerebral Circulation

    by Rira Choi, Jelena Mihailovic, Prapti Sharma, Fadi Nikola, Sydney L. Bluestein, Pramath Doddaballapur, Nicole Guerrera, Nebal S. Abu Hussein, Cristina Cavinato, Taylor S. Adams, et al.

    We hypothesized that vascular maladaptations resulting from chronic hypoxemia worsen end‐organ function via insidious positive feedback. To test this hypothesis in the systemic circulation, we quantified brain perfusion and left heart function and then biomechanically phenotyped the left common carotid artery (LCCA) in adult female mice under normoxic (21% oxygen) and chronic hypoxic (10%) conditions. Functional MRI revealed that hypoxia impaired cerebrovascular reactivity during transient hypercapnia (pCO 2 5%) while echocardiography revealed altered left ventricular diastolic, but not systolic, function. These end organ changes associated with an 18.8% decrease in distensibility of the LCCA due to a 34.4% increase in circumferential material stiffness without an increase in wall thickness. This finding suggested a change in the state (e.g., collagen microstructure), not amount, of the LCCA extracellular matrix. Active biaxial testing of the LCCA further revealed up to an 11% reduction of SMC contractility in response to vasoactive agents. Treatment with the mTOR inhibitor rapamycin improved LCCA properties in hypoxic mice, as reflected by a 53.37% increase in distensibility and a 43% improvement in contractility relative to the hypoxic group. We conclude that chronic hypoxia causes multiorgan effects: stiffer carotid arteries having impaired vascular reactivity associate with impaired cerebral and cardiac function. Maladaptive LCCA changes are prevented with mTOR inhibition during hypoxia, suggesting mTOR as a potential target to break the insidious feedback loop that leads to hypoxia‐induced maladaptive remodeling and to mitigate associated end‐organ dysfunction, with possible advantages to single ventricle patients who experience long periods of hypoxemia.


  • Open Access

    Proximal Pulmonary Artery Stiffening as a Biomarker of Cardiopulmonary Aging

    by Ruben De Man, Zhongyu Cai, Pramath Doddaballapur, Nicole Guerrera, Alexandria Regan, Liqin Lin, Erica Schwarz, Aurelien Justet, Nebal S. Abu Hussein, Jack Di Palo, et al.

    The geroscience hypothesis suggests that understanding mechanisms underlying aging will enable us to delay and lessen age‐related disability and diseases. The role of mechanical factors has been increasingly appreciated in many aspects of the aging process. Here, we use mouse models to investigate changes in the biomechanics of the proximal pulmonary artery, lung function, and right ventricle function in aging. We found an age‐related decreased capacity to store energy and increased circumferential stiffness of the proximal pulmonary artery with age that is associated with a reorientation of collagen toward the circumferential direction, decreased exercise ability, and decreased function of the lung and right ventricle. The observed compromised mechanics in the proximal pulmonary artery are consistent across multiple mouse models of accelerated aging. Furthermore, transcriptional changes in the proximal pulmonary artery indicate that aging is associated with senescence of perivascular macrophages, adventitial fibroblasts, and medial smooth muscle cells. Older pulmonary arteries increase expression of genes associated with ECM turnover (including genes in the TGFβ pathway) and increased intercellular signaling amongst perivascular macrophages, fibroblasts, and smooth muscle cells. Our results provide promising biomarkers of aging for diagnosis and potential pathways and molecular targets for antiaging therapies.